Quick Answer
Rani Therapeutics Holdings, Inc. reported Total Assets of $58.62 million for the year ending 2025.
- Rani Therapeutics Holdings, Inc. showed an increase of +60.0% in Total Assets from 2024 to 2025.
- This data is from Rani Therapeutics Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $77.32 million | Q3 2021: $136.96 million | Q1 2022: $115.31 million | Q2 2022: $104.34 million | Q3 2022: $108.20 million | Q1 2023: $96.45 million | Q2 2023: $83.51 million | Q3 2023: $70.44 million | Q1 2024: $53.51 million | Q2 2024: $43.73 million | Q3 2024: $43.54 million | Q1 2025: $24.13 million | Q2 2025: $16.90 million | Q3 2025: $10.14 million.
- Over the full 6 years of available data (2020 to 2025), Rani Therapeutics Holdings, Inc.'s Total Assets has declined by 26.2%.
- Historical annual values: Fiscal year 2025: $58.62 million | Fiscal year 2024: $36.63 million | Fiscal year 2023: $57.92 million | Fiscal year 2022: $108.03 million | Fiscal year 2021: $124.21 million | Fiscal year 2020: $79.42 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: